The final, formatted version of the article will be published soon.
REVIEW article
Front. Med.
Sec. Pulmonary Medicine
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1470381
This article is part of the Research Topic Eosinophilic Inflammation in Chronic Lung Diseases: Emerging Molecular Insights and Therapeutic Strategy View all 4 articles
Eosinophils: old cells, new directions
Provisionally accepted- 1 Research Unit, University Hospital of Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
- 2 Department of Pulmonology, University Hospital of Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
- 3 University Hospital Dr. Negrín. Hematology Department., Las Palmas de Gran Canaria, Spain
Eosinophils are polymorphonuclear cells that have progressively gained attention due to their involvement in multiple diseases and, more recently, in various homeostatic processes. Their well-known roles range from asthma and parasitic infections to less prevalent diseases such as eosinophilic granulomatosis with polyangiitis, eosinophilic esophagitis, and hypereosinophilic syndrome. In recent years, various biological therapies targeting these cells have been developed, altering the course of eosinophilic pathologies. Recent research has demonstrated differences in eosinophil subtypes and their functions. The presence of distinct classes of eosinophils has led to the theory of resident eosinophils (rEos) and inflammatory eosinophils (iEos). Subtype differences are determined by the pattern of protein expression on the cell membrane and the localization of eosinophils. Most of this research has been conducted in murine models, but several studies confirm these findings in peripheral blood and tissue. The objective of this review is to provide a comprehensive analysis of eosinophils, by recent findings that divide this cell line into two distinct populations with different functions and purposes.
Keywords: Asthma, COPD, Eosinophils, subtypes, Inflammation
Received: 25 Jul 2024; Accepted: 20 Dec 2024.
Copyright: © 2024 Santos, Socrro Ávila, Galván Fernández, Castellano, Cazorla Rivero and Cabrera López. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Carlos Cabrera López, Department of Pulmonology, University Hospital of Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.